| answer text |
<p>Our investment in the Coalition for Epidemic Preparedness Innovations (CEPI) supports
ongoing vaccine research and development to respond to an evolving virus. Whilst there
are no current plans for United Kingdom Government-initiated international research
into the COVID-19 vaccine response on immunocompromised groups, it is important to
emphasise that the research community is truly global in its collaboration and studies,
those planned or published, will be shared, discussed and closely scrutinised by international
researchers in this field and vice versa.</p><p>UK Research and Innovation is funding
research on vaccine responses in groups of immune-suppressed individuals specifically,
as part of its support for the OCTAVE study. This study includes those with inflammatory
disorders, high risk cancer patient groups, and patients with severe kidney and liver
disease.</p>
|
 |
